Elder Pharma to launch 32-35 new products over next 30-months

MUMBAI: The Rs 800-crore Elder Pharmaceuticals Limited plans to launch almost three dozen new products in the coming 30 months, a top company official said.

"We plans to launch almost 32-35 new products in the coming 30 months in niche therapeutic segments like female healthcare, osteoporosis, dermatology, pain management, cardiology, nutraceuticals, wound care and vitamin supplements," Elder Pharmaceuticals Director, Alok Saxena told PTI here.

This will consist of a combination of in-licensed and own products although the larger focus will be on self-researched products, Saxena said.

Elder Pharmaceuticals has a state-of-the-art Research and Development Centre at Navi Mumbai which is recognised by the Department of Scientific & Industrial Research, Ministry of Science & Technology. The R&D centre has recently been modernised and expanded and now consists of about 100 scientists.

"We are looking at launching at least 8-9 products each in the women's healthcare & nutraceuticals segments which are growing at an average of 18-20 per cent annually - higher than the 12-13 per cent growth rate of the overall domestic pharma industry," Saxena said.